Parallel Advisors’s TG Therapeutics TGTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.48K | Sell |
69
-48
| -41% | -$1.73K | ﹤0.01% | 2961 |
|
2025
Q1 | $4.61K | Buy |
117
+27
| +30% | +$1.07K | ﹤0.01% | 2697 |
|
2024
Q4 | $2.71K | Sell |
90
-9
| -9% | -$271 | ﹤0.01% | 2841 |
|
2024
Q3 | $2.32K | Buy |
99
+55
| +125% | +$1.29K | ﹤0.01% | 2837 |
|
2024
Q2 | $783 | Buy |
+44
| New | +$783 | ﹤0.01% | 3002 |
|
2024
Q1 | – | Sell |
-435
| Closed | -$7.43K | – | 3401 |
|
2023
Q4 | $7.43K | Hold |
435
| – | – | ﹤0.01% | 2396 |
|
2023
Q3 | $3.64K | Hold |
435
| – | – | ﹤0.01% | 2613 |
|
2023
Q2 | $10.8K | Hold |
435
| – | – | ﹤0.01% | 2140 |
|
2023
Q1 | $6.54K | Hold |
435
| – | – | ﹤0.01% | 2313 |
|
2022
Q4 | $5.15K | Hold |
435
| – | – | ﹤0.01% | 2319 |
|
2022
Q3 | $3K | Hold |
435
| – | – | ﹤0.01% | 2513 |
|
2022
Q2 | $2K | Buy |
+435
| New | +$2K | ﹤0.01% | 2627 |
|
2022
Q1 | – | Sell |
-528
| Closed | -$10K | – | 3275 |
|
2021
Q4 | $10K | Buy |
528
+478
| +956% | +$9.05K | ﹤0.01% | 2120 |
|
2021
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 2718 |
|
2021
Q2 | $2K | Sell |
50
-14
| -22% | -$560 | ﹤0.01% | 2592 |
|
2021
Q1 | $3K | Hold |
64
| – | – | ﹤0.01% | 2389 |
|
2020
Q4 | $3K | Buy |
64
+19
| +42% | +$891 | ﹤0.01% | 2206 |
|
2020
Q3 | $1K | Hold |
45
| – | – | ﹤0.01% | 2475 |
|
2020
Q2 | $0 | Buy |
+45
| New | – | ﹤0.01% | 2707 |
|